The U.S. Food and Drug Administration has approved Pfizer's Padcev (enfortumab vedotin-ejfv), a Nectin-4 directed antibody-drug conjugate, as a perioperative neoadjuvant treatment and postcystectomy ...
The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...
From the Uresta Starter Kit, a woman selects one of the bladder support device sizes to find her best fit for comfort and effectiveness. A femtech startup is bringing a non-surgical solution for women ...
Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based detection of molecular residual disease may identify patients at high risk for ...
To make life easier for people with a common bladder condition, Medtronic is digging in far away from urinary tract. Treatment for urinary urge incontinence can require pads, absorbent underwear and ...
Doctors at a South Shore animal hospital treated a turtle with a baseball-sized bladder stone on Wednesday.According to a social media post by the New England Wildlife Center, the chelonian had a ...
NEW HAVEN, Conn. (WTNH) — The FDA recently approved the first breakthrough treatment for bladder cancer in 40 years. It comes at a time when Coach Prime – Deion Sanders – is sharing his bladder cancer ...
The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
The FDA has signed off on Johnson & Johnson’s highly anticipated bladder cancer drug Inlexzo, marking an advance in the ability to care for patients who otherwise face bladder removal and limited ...
Do you pee a lot or feel the urge to go when you are feeling anxious or stressed? You are not alone. Research indicates a positive correlation between the severity of anxiety symptoms and overactive ...
Bladder cancer is mainly urothelial carcinoma, with non-muscle-invasive and muscle-invasive types, and smoking as a key risk factor. Diagnosis involves cystoscopy, biopsy, urine cytology, and imaging ...
The National Institute for Health and Care Excellence (NICE) has recommended the combination of enfortumab vedotin (Padcev, Astellas) with pembrolizumab (Keytruda, MSD) as a first-line option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results